1. Nayudu PL, Lopata A, Jones GM, Gook DA, Bourne HM, Sheather SJ, Brown TC, Johnston WI. An analysis of human oocytes and follicles from stimulated cycles: oocyte morphology and associated follicular fluid characteristics. Hum Reprod. 1989. 4:558–567.
2. Kawano Y, Fukuda J, Nasu K, Nishida M, Narahara H, Miyakawa I. Production of macrophage inflammatory protein-α in human follicular fulid and culture egranulosa cells. Fertil Steril. 2004. 82:1206–1211.
3. Ocal P, Aydin S, Cepni I, Idil S, Idil M, Uzun H, Benian A. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome? Eur J Obstet Gynecol Reprod Biol. 2004. 115:194–199.
Article
4. Cunha-Filho JS, Lemos NA, Freitas FM, Kiefer K, Faller M, Passos EP. Insulin-like growth factor (IGF)-1 and IGF binding protein-1 and -3 in the follicular fluid of infertile patients with endometriosis. Hum Reprod. 2003. 18:423–428.
Article
5. Hong SJ, Tse JY, Ho PC, Yeung WS. Cumulus cells reduce the spermatozoa-zona binding inhibitory activity of human follicular fluid. Fertil Steril. 2003. 79:802–807.
6. Anderson NG, Anderson NL. Twenty years of two-dimensional electrophoresis: past, present and future. Electrophoresis. 1996. 17:443–453.
Article
7. Washburn MP, Wolters D, Yates JR III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol. 2001. 19:242–247.
Article
8. Ryu JW, Kim HJ, Lee YS, Myong NH, Hwang CH, Lee GS, Yom HC. The proteomic approach to find biomarkers in gastric cancer. J Korean Med Sci. 2003. 18:505–509.
9. Fryksdale BG, Jedrzejewski PT, Wong DL, Gaerther AL, Miller BS. Impact of de-glycosylation methods on two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry for proteomic analysis. Electrophoresis. 2002. 23:2184–2193.
Article
10. Anahory T, Dechaud H, Bennes R, Marin P, Lamb NJ, Laoudj D. Identification of new proteins in follicular fluid of mature human follicles. Electrophoresis. 2002. 23:1197–1202.
Article
11. Hughes GJ, Frutiger S, Paquet N, Ravier F, Pasquali C, Sanchez JC, James R, Tissot JD, Bjellqvist , Hochstrasser DF. Plasma protein map: an update by microsequencing. Electrophoresis. 1992. 13:707–714.
Article
12. Abdullaev FI, MacVicar C, Frenkel GD. Inhibition by selenium of DNA and RNA synthesis in normal and malignant human cells in vitro. Cancer Lett. 1992. 65:43–49.
Article
13. Spyrou G, Bjornstedt M, Kumar S, Holmgren A. AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione. FEBS Lett. 1995. 368:59–63.
Article
14. Sinha R, Medina D. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. Carcinogenesis. 1997. 18:1541–1547.
Article
15. Fiala ES, Staretz ME, Pandya GA, El-Bayoumy K, Hamilton SR. Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis. 1998. 19:597–604.
Article
16. Swaney JB, Braithwaite F, Eder HA. Characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry. 1977. 16:271–278.
Article
17. Lefevre M, Roheim PS. Metabolism of apolipoprotein A-IV. J Lipid Res. 1984. 25:1603–1610.
Article
18. Shen WJ, Sridhar K, Bernlohr DA, Kraemer FB. Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein. Proc Natl Acad Sci USA. 1999. 96:5528–5532.
Article
19. Holm C, Österlund T, Laurell H, Contreras JA. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr. 2000. 20:365–393.
Article
20. Londos C, Brasaemle DL, Schultz CJ, Segrest JP, Kimmel AR. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol. 1999. 10:51–58.
Article
21. Sztalryd C, Xu G, Dorward H, Tansey JT, Contreras JA, Kimmel AR, Londos C. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol. 2003. 161:1093–1103.
Article
22. Faulds G, Ryden M, Ek I, Wahrenberg H, Arner P. Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome. J Clin Endocrinol Metab. 2003. 88:2269–2273.
Article
23. Osuga J, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A, Shionoiri F, Yahagi N, Kraemer FB, Tsutsumi O, Yamada N. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA. 2000. 97:787–792.
Article
24. Østerlund T. Structure-function relationships of hormone-sensitive lipase. Eur J Biochem. 2001. 268:1899–1907.
Article